Doctor profile · Federal record
Dr. Rekha Kumar, MD
Endocrinology, Diabetes & Metabolism Physician · New York, NY
- NPI 1598922023
- 18 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1165 York Avenue, Ground Floor
New York, NY 10065
(646) 962-2111
fax (646) 962-0159
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- August 1, 2019
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #250986
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598922023. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$101
Transactions
4
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 3 | $80.05 | |
| Novo Nordisk Inc | 1 | $21.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
667
Patients
157
Total drug cost
$333,491
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metformin Hcl Er (Metformin Hcl) | Brand | 130 | 51 | $2,530 |
| Ozempic (Semaglutide) | Brand | 115 | 23 | $145,787 |
| Mounjaro (Tirzepatide) | Brand | 86 | 17 | $122,552 |
| Atorvastatin Calcium | Generic | 46 | 19 | $488 |
| Synthroid (Levothyroxine Sodium) | Brand | 45 | 18 | $5,586 |
| Levothyroxine Sodium | Generic | 40 | 17 | $682 |
| Metformin Hcl | Generic | 37 | 12 | $504 |
| Topiramate | Generic | 35 | 0 | $488 |
| Alendronate Sodium | Generic | 28 | 0 | $372 |
| Rybelsus (Semaglutide) | Brand | 20 | 0 | $19,080 |
Frequently asked questions
What is Dr. Rekha Kumar's medical specialty?
Dr. Rekha Kumar practices Endocrinology, Diabetes & Metabolism Physician in New York, NY.
Where does Dr. Rekha Kumar practice?
Dr. Rekha Kumar practices at 1165 York Avenue, New York, NY 10065. Office phone: 6469622111.
What is Dr. Rekha Kumar's NPI?
Dr. Rekha Kumar's National Provider Identifier (NPI) is 1598922023, issued by NPPES.